Inpart is the leading global platform for science partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. 

In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry.   ​

The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations.   ​

Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.   ​

Biotechnology

Life Sciences

Pharmaceutical

Inpart

Gilles T.

Joachim Eeckhout

Anis Rokbani

Charleen Violas

Sarah Issa

Patrick S.

Sandrine Chambre

Steffina Tagoreraj

Robin K.

Bo Alroe

Inpart

Org chart

Similar companies